Financials
- Market Capitalization 28.7 M
- Employee 40
- Founded 2015
- CEO N/A
- Website www.nextcure.com
- Headquarter Delaware, United States
- FIGI BBG00BTH5153
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.72
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4341 | QNCX Quince Therapeutics, Inc. - Common Stock | 31.73 USD | 0.00% | +15.80% | +8.37% | +1494.47% | 32.27 M USD | ||
| 4350 | CVM Cel-Sci Corporation Common Stock | 1.76 USD | -5.88% | -37.14% | +18.92% | -65.83% | 30.96 M USD | ||
| 4380 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.71 USD | +4.91% | -1.72% | +3.64% | -82.02% | 28.95 M USD | ||
| 4381 | EDSA Edesa Biotech, Inc. - Common Shares | 2.91 USD | -1.02% | -23.62% | -34.31% | +14.12% | 28.06 M USD |